Non-alcoholic fatty liver disease (NAFLD) represents a range of progressive liver diseases that include steatosis, NASH, fibrosis, and ultimately, liver cirrhosis. The Cisbio NAFLD guide provides an up-to-date snapshot of current NAFLD molecular pathophysiology. The guide: Summarises the fundamentals of NAFLD and NASH Reviews key cell types and proteins involved in liver disease Details molecular […]
READ MOREYour Islets are precious, try Cisbio’s Ultra Sensitive Insulin Assay One hurdle faced by researchers seeking to quantify insulin is the high number of islets often required per assay. Designed for enhanced sensitivity, this kit is intended for the quantification of insulin in low-concentration samples. The kit is ideal for the detection of basal insulin […]
READ MOREBTK is involved in the B cell receptor and the NF kappa B signalling pathways. It has an important role in primary immunodeficiency, in particularly, X-linked agammaglobulinemia (XLA) disease. Cisbio’s phospho- and total BTK assays are based on a time-resolved (TR)-FRET sandwich immunoassay format comprising two specific anti-BTK antibodies, one labeled with Eu3+-cryptate (donor) and […]
READ MOREMore convenient and faster than either ELISA or Western blot, Cisbio assays for the detection of Phospho- and total P53 are: Highly sensitivity: 4-fold > than western blot Easy and fast: Add & mix approach with no washing! Flexible: use frozen lysates or cells in culture Economical: adaptable for 96- to 1536-well plates Read more…
READ MORETag-lite is highly advantageous for GPCR and RTK investigations, as well as biotherapeutic antibody development. This technology combining HTRF with SNAP-tag®, CLIP-tag® and HaloTag®technologies, offers an alternative to existing cellular bioluminescence resonance energy transfer (BRET) and FRET assays, providing a new targeted way to label your protein of interest. Key features Non-radioactive Homegeneous & filtration-free […]
READ MORE




